Loss of E-cadherin increases metastasic potential of melanoma

被引：0
作者：
Larue, Lionel [1 ]
Luciani, Falvie [1 ]
Beermann, Friedrich [3 ]
Kemler, Rolf [2 ]
Delmas, Veronique [1 ]
机构：
[1] CNRS, INSERM, Inst Curie, U1021,UMR 146, F-91405 Orsay, France
[2] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany
[3] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [41] The effect of E-cadherin loss on melanoma progression and markers of epithelial-mesenchymal transition in a conditional mouse model
    Rosenbaum, L. E.
    Damsky, W. E.
    Bosenberg, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S126 - S126
  • [42] a-Catulin downregulates E-cadherin and promotes melanoma progression and invasion
    Kreiseder, Birgit
    Orel, Lukas
    Bujnow, Constantin
    Buschek, Stefan
    Pflueger, Maren
    Schuett, Wolfgang
    Hundsberger, Harald
    de Martin, Rainer
    Wiesner, Christoph
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (03) : 521 - 530
  • [43] Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the Bladder
    Keck, Bastian
    Wach, Sven
    Kunath, Frank
    Bertz, Simone
    Taubert, Helge
    Lehmann, Jan
    Stoeckle, Michael
    Wullich, Bernd
    Hartmann, Arndt
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2440 - 2445
  • [44] Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the Bladder
    Bastian Keck
    Sven Wach
    Frank Kunath
    Simone Bertz
    Helge Taubert
    Jan Lehmann
    Michael Stöckle
    Bernd Wullich
    Arndt Hartmann
    Annals of Surgical Oncology, 2013, 20 : 2440 - 2445
  • [45] E-cadherin: A potential biomarker of colorectal cancer prognosis (Review)
    Christou, Niki
    Perraud, Aurelie
    Blondy, Sabrina
    Jauberteau, Marie-Odile
    Battu, Serge
    Mathonnet, Muriel
    ONCOLOGY LETTERS, 2017, 13 (06) : 4571 - 4576
  • [46] The clinicopathological significance and potential drug target of E-cadherin in NSCLC
    Zhong, Kaize
    Chen, Weiwen
    Xiao, Ning
    Zhao, Jian
    TUMOR BIOLOGY, 2015, 36 (08) : 6139 - 6148
  • [47] E-Cadherin Regulates Mitochondrial Membrane Potential in Cancer Cells
    Begum, Hydari Masuma
    Mariano, Chelsea
    Zhou, Hao
    Shen, Keyue
    CANCERS, 2021, 13 (20)
  • [48] Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
    Graff, JR
    Gabrielson, E
    Fujii, H
    Baylin, SB
    Herman, JG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2727 - 2732
  • [49] The role of E-cadherin expression and E-cadherin gene promoter hypermethylation in gastric carcinoma
    Hamed, Mohamed K. F.
    Fawzy, Gamal
    Hanna, Hanna H.
    EGYPTIAN JOURNAL OF SURGERY, 2019, 38 (02) : 361 - 368
  • [50] Anaplastic Meningioma with Single Cell Infiltration and Loss of E-Cadherin Immunoreactivity
    Danielson, Brett
    Munoz, David
    Karamchandani, Jason
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (06) : 572 - 573
12345